Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Perel

Showing results (111-120 of 240) with videos related to

Pageof 24
Sort By:
The American Journal of Psychiatry|December 1, 1986
Paradoxical effects of amitriptyline on borderline patientsP H Soloff, A George, R S Nathan, et al.
Archives of General Psychiatry|February 1, 1977
Clinical implications of imipramine plasma levels for depressive illnessA H Glassman, J M Perel, M Shostak, et al.
Advances in Biochemical Psychopharmacology|January 1, 1974
Imipramine and chlorpromazine in hepatic microsomal systemsJ M Perel, L O'Brien, N B Black, et al.
Psychopharmacology Bulletin|January 1, 1992
Relationship of pharmacologic compliance to long-term prophylaxis in recurrent depressionE Frank, J M Perel, A G Mallinger, et al.
Psychopharmacology Bulletin|January 1, 1987
Behavioral dyscontrol in borderline patients treated with amitriptylineP H Soloff, A George, R S Nathan, et al.
Psychopharmacology Bulletin|January 1, 1993
Haloperidol vs. phenelzine in continuation therapy of borderline disorderJ R Cornelius, P H Soloff, A George, et al.
Journal of Chromatography. B, Biomedical Applications|June 23, 1995
Quantitative determination of perphenazine and its metabolites in plasma by high-performance liquid chromatography and coulometric detectionJ P Foglia, D Sorisio, M A Kirshner, et al.
Haematologica|November 4, 2005
Clinical significance of development of Philadelphia-chromosome negative clones in patients with chronic myeloid leukemia treated with imatinib mesylateJ M Perel, C McCarthy, O Walker, et al.
Lancet (London, England)|February 26, 1977
No effects of quaternary neuroleptics on human prolactin and adenylcyclaseG Langer, H S Ahn, J M Perel, et al.
Journal of Medicinal Chemistry|December 22, 2011
Metabolic studies with deuterated phenobarbitalJ M Perel, P G Dayton, C L Tauriello, et al.
Pageof 24

Showing results (111-120 of 240) with videos related to

Sort By:
Pageof 24
The American Journal of Psychiatry|December 1, 1986
Paradoxical effects of amitriptyline on borderline patientsP H Soloff, A George, R S Nathan, et al.
Archives of General Psychiatry|February 1, 1977
Clinical implications of imipramine plasma levels for depressive illnessA H Glassman, J M Perel, M Shostak, et al.
Advances in Biochemical Psychopharmacology|January 1, 1974
Imipramine and chlorpromazine in hepatic microsomal systemsJ M Perel, L O'Brien, N B Black, et al.
Psychopharmacology Bulletin|January 1, 1992
Relationship of pharmacologic compliance to long-term prophylaxis in recurrent depressionE Frank, J M Perel, A G Mallinger, et al.
Psychopharmacology Bulletin|January 1, 1987
Behavioral dyscontrol in borderline patients treated with amitriptylineP H Soloff, A George, R S Nathan, et al.
Psychopharmacology Bulletin|January 1, 1993
Haloperidol vs. phenelzine in continuation therapy of borderline disorderJ R Cornelius, P H Soloff, A George, et al.
Journal of Chromatography. B, Biomedical Applications|June 23, 1995
Quantitative determination of perphenazine and its metabolites in plasma by high-performance liquid chromatography and coulometric detectionJ P Foglia, D Sorisio, M A Kirshner, et al.
Haematologica|November 4, 2005
Clinical significance of development of Philadelphia-chromosome negative clones in patients with chronic myeloid leukemia treated with imatinib mesylateJ M Perel, C McCarthy, O Walker, et al.
Lancet (London, England)|February 26, 1977
No effects of quaternary neuroleptics on human prolactin and adenylcyclaseG Langer, H S Ahn, J M Perel, et al.
Journal of Medicinal Chemistry|December 22, 2011
Metabolic studies with deuterated phenobarbitalJ M Perel, P G Dayton, C L Tauriello, et al.
Pageof 24